- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
According to our latest study, the global Active Hemostatic Agents market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Active hemostatic agents are standard surgical techniques to manage bleeding from surgical surfaces. Active hemostatic agents are used in a wide variety of surgical settings, and the evolution of this class of surgical tools helps in the progress of active hemostats into present-day surgery and urology, and highlight opportunities for future research.
This report is a detailed and comprehensive analysis for global Active Hemostatic Agents market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Active Hemostatic Agents market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Active Hemostatic Agents market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Active Hemostatic Agents market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Active Hemostatic Agents market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Active Hemostatic Agents
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Active Hemostatic Agents market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic Plc., Ethicon Inc., Pfizer Inc., Baxter International Inc. and CryoLife Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Active Hemostatic Agents market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Thrombin based hemostats
Surgical Sealants
Combination Products
Market segment by Application
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Major players covered
Medtronic Plc.
Ethicon Inc.
Pfizer Inc.
Baxter International Inc.
CryoLife Inc.
Integra Life Sciences Corporation, etc.
Stryker
Biom’up
BD
Johnson & Johnson Services
C.R.Bard
B. Braun Melsungen AG
Z-Medica LLC
Advanced Medical Solutions Group plc
GELITA GA
Active Hemostatic Agents
Warrior Tactical, LLC
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Active Hemostatic Agents product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Active Hemostatic Agents, with price, sales, revenue and global market share of Active Hemostatic Agents from 2018 to 2023.
Chapter 3, the Active Hemostatic Agents competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Active Hemostatic Agents breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Active Hemostatic Agents market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Active Hemostatic Agents.
Chapter 14 and 15, to describe Active Hemostatic Agents sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Active Hemostatic Agents
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Active Hemostatic Agents Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Thrombin based hemostats
1.3.3 Surgical Sealants
1.3.4 Combination Products
1.4 Market Analysis by Application
1.4.1 Overview: Global Active Hemostatic Agents Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Ambulatory Surgical Centers
1.4.4 Specialty Clinics
1.5 Global Active Hemostatic Agents Market Size & Forecast
1.5.1 Global Active Hemostatic Agents Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Active Hemostatic Agents Sales Quantity (2018-2029)
1.5.3 Global Active Hemostatic Agents Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Medtronic Plc.
2.1.1 Medtronic Plc. Details
2.1.2 Medtronic Plc. Major Business
2.1.3 Medtronic Plc. Active Hemostatic Agents Product and Services
2.1.4 Medtronic Plc. Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Medtronic Plc. Recent Developments/Updates
2.2 Ethicon Inc.
2.2.1 Ethicon Inc. Details
2.2.2 Ethicon Inc. Major Business
2.2.3 Ethicon Inc. Active Hemostatic Agents Product and Services
2.2.4 Ethicon Inc. Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Ethicon Inc. Recent Developments/Updates
2.3 Pfizer Inc.
2.3.1 Pfizer Inc. Details
2.3.2 Pfizer Inc. Major Business
2.3.3 Pfizer Inc. Active Hemostatic Agents Product and Services
2.3.4 Pfizer Inc. Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Pfizer Inc. Recent Developments/Updates
2.4 Baxter International Inc.
2.4.1 Baxter International Inc. Details
2.4.2 Baxter International Inc. Major Business
2.4.3 Baxter International Inc. Active Hemostatic Agents Product and Services
2.4.4 Baxter International Inc. Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Baxter International Inc. Recent Developments/Updates
2.5 CryoLife Inc.
2.5.1 CryoLife Inc. Details
2.5.2 CryoLife Inc. Major Business
2.5.3 CryoLife Inc. Active Hemostatic Agents Product and Services
2.5.4 CryoLife Inc. Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 CryoLife Inc. Recent Developments/Updates
2.6 Integra Life Sciences Corporation, etc.
2.6.1 Integra Life Sciences Corporation, etc. Details
2.6.2 Integra Life Sciences Corporation, etc. Major Business
2.6.3 Integra Life Sciences Corporation, etc. Active Hemostatic Agents Product and Services
2.6.4 Integra Life Sciences Corporation, etc. Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Integra Life Sciences Corporation, etc. Recent Developments/Updates
2.7 Stryker
2.7.1 Stryker Details
2.7.2 Stryker Major Business
2.7.3 Stryker Active Hemostatic Agents Product and Services
2.7.4 Stryker Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Stryker Recent Developments/Updates
2.8 Biom’up
2.8.1 Biom’up Details
2.8.2 Biom’up Major Business
2.8.3 Biom’up Active Hemostatic Agents Product and Services
2.8.4 Biom’up Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Biom’up Recent Developments/Updates
2.9 BD
2.9.1 BD Details
2.9.2 BD Major Business
2.9.3 BD Active Hemostatic Agents Product and Services
2.9.4 BD Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 BD Recent Developments/Updates
2.10 Johnson & Johnson Services
2.10.1 Johnson & Johnson Services Details
2.10.2 Johnson & Johnson Services Major Business
2.10.3 Johnson & Johnson Services Active Hemostatic Agents Product and Services
2.10.4 Johnson & Johnson Services Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Johnson & Johnson Services Recent Developments/Updates
2.11 C.R.Bard
2.11.1 C.R.Bard Details
2.11.2 C.R.Bard Major Business
2.11.3 C.R.Bard Active Hemostatic Agents Product and Services
2.11.4 C.R.Bard Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 C.R.Bard Recent Developments/Updates
2.12 B. Braun Melsungen AG
2.12.1 B. Braun Melsungen AG Details
2.12.2 B. Braun Melsungen AG Major Business
2.12.3 B. Braun Melsungen AG Active Hemostatic Agents Product and Services
2.12.4 B. Braun Melsungen AG Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 B. Braun Melsungen AG Recent Developments/Updates
2.13 Z-Medica LLC
2.13.1 Z-Medica LLC Details
2.13.2 Z-Medica LLC Major Business
2.13.3 Z-Medica LLC Active Hemostatic Agents Product and Services
2.13.4 Z-Medica LLC Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Z-Medica LLC Recent Developments/Updates
2.14 Advanced Medical Solutions Group plc
2.14.1 Advanced Medical Solutions Group plc Details
2.14.2 Advanced Medical Solutions Group plc Major Business
2.14.3 Advanced Medical Solutions Group plc Active Hemostatic Agents Product and Services
2.14.4 Advanced Medical Solutions Group plc Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Advanced Medical Solutions Group plc Recent Developments/Updates
2.15 GELITA GA
2.15.1 GELITA GA Details
2.15.2 GELITA GA Major Business
2.15.3 GELITA GA Active Hemostatic Agents Product and Services
2.15.4 GELITA GA Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 GELITA GA Recent Developments/Updates
2.16 Active Hemostatic Agents
2.16.1 Active Hemostatic Agents Details
2.16.2 Active Hemostatic Agents Major Business
2.16.3 Active Hemostatic Agents Active Hemostatic Agents Product and Services
2.16.4 Active Hemostatic Agents Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Active Hemostatic Agents Recent Developments/Updates
2.17 Warrior Tactical, LLC
2.17.1 Warrior Tactical, LLC Details
2.17.2 Warrior Tactical, LLC Major Business
2.17.3 Warrior Tactical, LLC Active Hemostatic Agents Product and Services
2.17.4 Warrior Tactical, LLC Active Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Warrior Tactical, LLC Recent Developments/Updates
3 Competitive Environment: Active Hemostatic Agents by Manufacturer
3.1 Global Active Hemostatic Agents Sales Quantity by Manufacturer (2018-2023)
3.2 Global Active Hemostatic Agents Revenue by Manufacturer (2018-2023)
3.3 Global Active Hemostatic Agents Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Active Hemostatic Agents by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Active Hemostatic Agents Manufacturer Market Share in 2022
3.4.2 Top 6 Active Hemostatic Agents Manufacturer Market Share in 2022
3.5 Active Hemostatic Agents Market: Overall Company Footprint Analysis
3.5.1 Active Hemostatic Agents Market: Region Footprint
3.5.2 Active Hemostatic Agents Market: Company Product Type Footprint
3.5.3 Active Hemostatic Agents Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Active Hemostatic Agents Market Size by Region
4.1.1 Global Active Hemostatic Agents Sales Quantity by Region (2018-2029)
4.1.2 Global Active Hemostatic Agents Consumption Value by Region (2018-2029)
4.1.3 Global Active Hemostatic Agents Average Price by Region (2018-2029)
4.2 North America Active Hemostatic Agents Consumption Value (2018-2029)
4.3 Europe Active Hemostatic Agents Consumption Value (2018-2029)
4.4 Asia-Pacific Active Hemostatic Agents Consumption Value (2018-2029)
4.5 South America Active Hemostatic Agents Consumption Value (2018-2029)
4.6 Middle East and Africa Active Hemostatic Agents Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Active Hemostatic Agents Sales Quantity by Type (2018-2029)
5.2 Global Active Hemostatic Agents Consumption Value by Type (2018-2029)
5.3 Global Active Hemostatic Agents Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Active Hemostatic Agents Sales Quantity by Application (2018-2029)
6.2 Global Active Hemostatic Agents Consumption Value by Application (2018-2029)
6.3 Global Active Hemostatic Agents Average Price by Application (2018-2029)
7 North America
7.1 North America Active Hemostatic Agents Sales Quantity by Type (2018-2029)
7.2 North America Active Hemostatic Agents Sales Quantity by Application (2018-2029)
7.3 North America Active Hemostatic Agents Market Size by Country
7.3.1 North America Active Hemostatic Agents Sales Quantity by Country (2018-2029)
7.3.2 North America Active Hemostatic Agents Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Active Hemostatic Agents Sales Quantity by Type (2018-2029)
8.2 Europe Active Hemostatic Agents Sales Quantity by Application (2018-2029)
8.3 Europe Active Hemostatic Agents Market Size by Country
8.3.1 Europe Active Hemostatic Agents Sales Quantity by Country (2018-2029)
8.3.2 Europe Active Hemostatic Agents Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Active Hemostatic Agents Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Active Hemostatic Agents Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Active Hemostatic Agents Market Size by Region
9.3.1 Asia-Pacific Active Hemostatic Agents Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Active Hemostatic Agents Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Active Hemostatic Agents Sales Quantity by Type (2018-2029)
10.2 South America Active Hemostatic Agents Sales Quantity by Application (2018-2029)
10.3 South America Active Hemostatic Agents Market Size by Country
10.3.1 South America Active Hemostatic Agents Sales Quantity by Country (2018-2029)
10.3.2 South America Active Hemostatic Agents Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Active Hemostatic Agents Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Active Hemostatic Agents Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Active Hemostatic Agents Market Size by Country
11.3.1 Middle East & Africa Active Hemostatic Agents Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Active Hemostatic Agents Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Active Hemostatic Agents Market Drivers
12.2 Active Hemostatic Agents Market Restraints
12.3 Active Hemostatic Agents Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Active Hemostatic Agents and Key Manufacturers
13.2 Manufacturing Costs Percentage of Active Hemostatic Agents
13.3 Active Hemostatic Agents Production Process
13.4 Active Hemostatic Agents Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Active Hemostatic Agents Typical Distributors
14.3 Active Hemostatic Agents Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Active Hemostatic Agents Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Active Hemostatic Agents Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Medtronic Plc. Basic Information, Manufacturing Base and Competitors
Table 4. Medtronic Plc. Major Business
Table 5. Medtronic Plc. Active Hemostatic Agents Product and Services
Table 6. Medtronic Plc. Active Hemostatic Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Medtronic Plc. Recent Developments/Updates
Table 8. Ethicon Inc. Basic Information, Manufacturing Base and Competitors
Table 9. Ethicon Inc. Major Business
Table 10. Ethicon Inc. Active Hemostatic Agents Product and Services
Table 11. Ethicon Inc. Active Hemostatic Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Ethicon Inc. Recent Developments/Updates
Table 13. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 14. Pfizer Inc. Major Business
Table 15. Pfizer Inc. Active Hemostatic Agents Product and Services
Table 16. Pfizer Inc. Active Hemostatic Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Pfizer Inc. Recent Developments/Updates
Table 18. Baxter International Inc. Basic Information, Manufacturing Base and Competitors
Table 19. Baxter International Inc. Major Business
Table 20. Baxter International Inc. Active Hemostatic Agents Product and Services
Table 21. Baxter International Inc. Active Hemostatic Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Baxter International Inc. Recent Developments/Updates
Table 23. CryoLife Inc. Basic Information, Manufacturing Base and Competitors
Table 24. CryoLife Inc. Major Business
Table 25. CryoLife Inc. Active Hemostatic Agents Product and Services
Table 26. CryoLife Inc. Active Hemostatic Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. CryoLife Inc. Recent Developments/Updates
Table 28. Integra Life Sciences Corporation, etc. Basic Information, Manufacturing Base and Competitors
Table 29. Integra Life Sciences Corporation, etc. Major Business
Table 30. Integra Life Sciences Corporation, etc. Active Hemostatic Agents Product and Services
Table 31. Integra Life Sciences Corporation, etc. Active Hemostatic Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Integra Life Sciences Corporation, etc. Recent Developments/Updates
Table 33. Stryker Basic Information, Manufacturing Base and Competitors
Table 34. Stryker Major Business
Table 35. Stryker Active Hemostatic Agents Product and Services
Table 36. Stryker Active Hemostatic Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Stryker Recent Developments/Updates
Table 38. Biom’up Basic Information, Manufacturing Base and Competitors
Table 39. Biom’up Major Business
Table 40. Biom’up Active Hemostatic Agents Product and Services
Table 41. Biom’up Active Hemostatic Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Biom’up Recent Developments/Updates
Table 43. BD Basic Information, Manufacturing Base and Competitors
Table 44. BD Major Business
Table 45. BD Active Hemostatic Agents Product and Services
Table 46. BD Active Hemostatic Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. BD Recent Developments/Updates
Table 48. Johnson & Johnson Services Basic Information, Manufacturing Base and Competitors
Table 49. Johnson & Johnson Services Major Business
Table 50. Johnson & Johnson Services Active Hemostatic Agents Product and Services
Table 51. Johnson & Johnson Services Active Hemostatic Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Johnson & Johnson Services Recent Developments/Updates
Table 53. C.R.Bard Basic Information, Manufacturing Base and Competitors
Table 54. C.R.Bard Major Business
Table 55. C.R.Bard Active Hemostatic Agents Product and Services
Table 56. C.R.Bard Active Hemostatic Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. C.R.Bard Recent Developments/Updates
Table 58. B. Braun Melsungen AG Basic Information, Manufacturing Base and Competitors
Table 59. B. Braun Melsungen AG Major Business
Table 60. B. Braun Melsungen AG Active Hemostatic Agents Product and Services
Table 61. B. Braun Melsungen AG Active Hemostatic Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. B. Braun Melsungen AG Recent Developments/Updates
Table 63. Z-Medica LLC Basic Information, Manufacturing Base and Competitors
Table 64. Z-Medica LLC Major Business
Table 65. Z-Medica LLC Active Hemostatic Agents Product and Services
Table 66. Z-Medica LLC Active Hemostatic Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Z-Medica LLC Recent Developments/Updates
Table 68. Advanced Medical Solutions Group plc Basic Information, Manufacturing Base and Competitors
Table 69. Advanced Medical Solutions Group plc Major Business
Table 70. Advanced Medical Solutions Group plc Active Hemostatic Agents Product and Services
Table 71. Advanced Medical Solutions Group plc Active Hemostatic Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Advanced Medical Solutions Group plc Recent Developments/Updates
Table 73. GELITA GA Basic Information, Manufacturing Base and Competitors
Table 74. GELITA GA Major Business
Table 75. GELITA GA Active Hemostatic Agents Product and Services
Table 76. GELITA GA Active Hemostatic Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. GELITA GA Recent Developments/Updates
Table 78. Active Hemostatic Agents Basic Information, Manufacturing Base and Competitors
Table 79. Active Hemostatic Agents Major Business
Table 80. Active Hemostatic Agents Active Hemostatic Agents Product and Services
Table 81. Active Hemostatic Agents Active Hemostatic Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Active Hemostatic Agents Recent Developments/Updates
Table 83. Warrior Tactical, LLC Basic Information, Manufacturing Base and Competitors
Table 84. Warrior Tactical, LLC Major Business
Table 85. Warrior Tactical, LLC Active Hemostatic Agents Product and Services
Table 86. Warrior Tactical, LLC Active Hemostatic Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Warrior Tactical, LLC Recent Developments/Updates
Table 88. Global Active Hemostatic Agents Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 89. Global Active Hemostatic Agents Revenue by Manufacturer (2018-2023) & (USD Million)
Table 90. Global Active Hemostatic Agents Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 91. Market Position of Manufacturers in Active Hemostatic Agents, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 92. Head Office and Active Hemostatic Agents Production Site of Key Manufacturer
Table 93. Active Hemostatic Agents Market: Company Product Type Footprint
Table 94. Active Hemostatic Agents Market: Company Product Application Footprint
Table 95. Active Hemostatic Agents New Market Entrants and Barriers to Market Entry
Table 96. Active Hemostatic Agents Mergers, Acquisition, Agreements, and Collaborations
Table 97. Global Active Hemostatic Agents Sales Quantity by Region (2018-2023) & (K Units)
Table 98. Global Active Hemostatic Agents Sales Quantity by Region (2024-2029) & (K Units)
Table 99. Global Active Hemostatic Agents Consumption Value by Region (2018-2023) & (USD Million)
Table 100. Global Active Hemostatic Agents Consumption Value by Region (2024-2029) & (USD Million)
Table 101. Global Active Hemostatic Agents Average Price by Region (2018-2023) & (US$/Unit)
Table 102. Global Active Hemostatic Agents Average Price by Region (2024-2029) & (US$/Unit)
Table 103. Global Active Hemostatic Agents Sales Quantity by Type (2018-2023) & (K Units)
Table 104. Global Active Hemostatic Agents Sales Quantity by Type (2024-2029) & (K Units)
Table 105. Global Active Hemostatic Agents Consumption Value by Type (2018-2023) & (USD Million)
Table 106. Global Active Hemostatic Agents Consumption Value by Type (2024-2029) & (USD Million)
Table 107. Global Active Hemostatic Agents Average Price by Type (2018-2023) & (US$/Unit)
Table 108. Global Active Hemostatic Agents Average Price by Type (2024-2029) & (US$/Unit)
Table 109. Global Active Hemostatic Agents Sales Quantity by Application (2018-2023) & (K Units)
Table 110. Global Active Hemostatic Agents Sales Quantity by Application (2024-2029) & (K Units)
Table 111. Global Active Hemostatic Agents Consumption Value by Application (2018-2023) & (USD Million)
Table 112. Global Active Hemostatic Agents Consumption Value by Application (2024-2029) & (USD Million)
Table 113. Global Active Hemostatic Agents Average Price by Application (2018-2023) & (US$/Unit)
Table 114. Global Active Hemostatic Agents Average Price by Application (2024-2029) & (US$/Unit)
Table 115. North America Active Hemostatic Agents Sales Quantity by Type (2018-2023) & (K Units)
Table 116. North America Active Hemostatic Agents Sales Quantity by Type (2024-2029) & (K Units)
Table 117. North America Active Hemostatic Agents Sales Quantity by Application (2018-2023) & (K Units)
Table 118. North America Active Hemostatic Agents Sales Quantity by Application (2024-2029) & (K Units)
Table 119. North America Active Hemostatic Agents Sales Quantity by Country (2018-2023) & (K Units)
Table 120. North America Active Hemostatic Agents Sales Quantity by Country (2024-2029) & (K Units)
Table 121. North America Active Hemostatic Agents Consumption Value by Country (2018-2023) & (USD Million)
Table 122. North America Active Hemostatic Agents Consumption Value by Country (2024-2029) & (USD Million)
Table 123. Europe Active Hemostatic Agents Sales Quantity by Type (2018-2023) & (K Units)
Table 124. Europe Active Hemostatic Agents Sales Quantity by Type (2024-2029) & (K Units)
Table 125. Europe Active Hemostatic Agents Sales Quantity by Application (2018-2023) & (K Units)
Table 126. Europe Active Hemostatic Agents Sales Quantity by Application (2024-2029) & (K Units)
Table 127. Europe Active Hemostatic Agents Sales Quantity by Country (2018-2023) & (K Units)
Table 128. Europe Active Hemostatic Agents Sales Quantity by Country (2024-2029) & (K Units)
Table 129. Europe Active Hemostatic Agents Consumption Value by Country (2018-2023) & (USD Million)
Table 130. Europe Active Hemostatic Agents Consumption Value by Country (2024-2029) & (USD Million)
Table 131. Asia-Pacific Active Hemostatic Agents Sales Quantity by Type (2018-2023) & (K Units)
Table 132. Asia-Pacific Active Hemostatic Agents Sales Quantity by Type (2024-2029) & (K Units)
Table 133. Asia-Pacific Active Hemostatic Agents Sales Quantity by Application (2018-2023) & (K Units)
Table 134. Asia-Pacific Active Hemostatic Agents Sales Quantity by Application (2024-2029) & (K Units)
Table 135. Asia-Pacific Active Hemostatic Agents Sales Quantity by Region (2018-2023) & (K Units)
Table 136. Asia-Pacific Active Hemostatic Agents Sales Quantity by Region (2024-2029) & (K Units)
Table 137. Asia-Pacific Active Hemostatic Agents Consumption Value by Region (2018-2023) & (USD Million)
Table 138. Asia-Pacific Active Hemostatic Agents Consumption Value by Region (2024-2029) & (USD Million)
Table 139. South America Active Hemostatic Agents Sales Quantity by Type (2018-2023) & (K Units)
Table 140. South America Active Hemostatic Agents Sales Quantity by Type (2024-2029) & (K Units)
Table 141. South America Active Hemostatic Agents Sales Quantity by Application (2018-2023) & (K Units)
Table 142. South America Active Hemostatic Agents Sales Quantity by Application (2024-2029) & (K Units)
Table 143. South America Active Hemostatic Agents Sales Quantity by Country (2018-2023) & (K Units)
Table 144. South America Active Hemostatic Agents Sales Quantity by Country (2024-2029) & (K Units)
Table 145. South America Active Hemostatic Agents Consumption Value by Country (2018-2023) & (USD Million)
Table 146. South America Active Hemostatic Agents Consumption Value by Country (2024-2029) & (USD Million)
Table 147. Middle East & Africa Active Hemostatic Agents Sales Quantity by Type (2018-2023) & (K Units)
Table 148. Middle East & Africa Active Hemostatic Agents Sales Quantity by Type (2024-2029) & (K Units)
Table 149. Middle East & Africa Active Hemostatic Agents Sales Quantity by Application (2018-2023) & (K Units)
Table 150. Middle East & Africa Active Hemostatic Agents Sales Quantity by Application (2024-2029) & (K Units)
Table 151. Middle East & Africa Active Hemostatic Agents Sales Quantity by Region (2018-2023) & (K Units)
Table 152. Middle East & Africa Active Hemostatic Agents Sales Quantity by Region (2024-2029) & (K Units)
Table 153. Middle East & Africa Active Hemostatic Agents Consumption Value by Region (2018-2023) & (USD Million)
Table 154. Middle East & Africa Active Hemostatic Agents Consumption Value by Region (2024-2029) & (USD Million)
Table 155. Active Hemostatic Agents Raw Material
Table 156. Key Manufacturers of Active Hemostatic Agents Raw Materials
Table 157. Active Hemostatic Agents Typical Distributors
Table 158. Active Hemostatic Agents Typical Customers
List of Figures
Figure 1. Active Hemostatic Agents Picture
Figure 2. Global Active Hemostatic Agents Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Active Hemostatic Agents Consumption Value Market Share by Type in 2022
Figure 4. Thrombin based hemostats Examples
Figure 5. Surgical Sealants Examples
Figure 6. Combination Products Examples
Figure 7. Global Active Hemostatic Agents Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Active Hemostatic Agents Consumption Value Market Share by Application in 2022
Figure 9. Hospitals Examples
Figure 10. Ambulatory Surgical Centers Examples
Figure 11. Specialty Clinics Examples
Figure 12. Global Active Hemostatic Agents Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Active Hemostatic Agents Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Active Hemostatic Agents Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Active Hemostatic Agents Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Active Hemostatic Agents Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Active Hemostatic Agents Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Active Hemostatic Agents by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Active Hemostatic Agents Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Active Hemostatic Agents Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Active Hemostatic Agents Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Active Hemostatic Agents Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Active Hemostatic Agents Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Active Hemostatic Agents Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Active Hemostatic Agents Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Active Hemostatic Agents Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Active Hemostatic Agents Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Active Hemostatic Agents Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Active Hemostatic Agents Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Active Hemostatic Agents Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Active Hemostatic Agents Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Active Hemostatic Agents Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Active Hemostatic Agents Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Active Hemostatic Agents Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Active Hemostatic Agents Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Active Hemostatic Agents Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Active Hemostatic Agents Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Active Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Active Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Active Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Active Hemostatic Agents Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Active Hemostatic Agents Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Active Hemostatic Agents Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Active Hemostatic Agents Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Active Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Active Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Active Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Active Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Active Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Active Hemostatic Agents Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Active Hemostatic Agents Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Active Hemostatic Agents Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Active Hemostatic Agents Consumption Value Market Share by Region (2018-2029)
Figure 54. China Active Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Active Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Active Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Active Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Active Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Active Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Active Hemostatic Agents Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Active Hemostatic Agents Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Active Hemostatic Agents Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Active Hemostatic Agents Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Active Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Active Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Active Hemostatic Agents Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Active Hemostatic Agents Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Active Hemostatic Agents Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Active Hemostatic Agents Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Active Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Active Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Active Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Active Hemostatic Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Active Hemostatic Agents Market Drivers
Figure 75. Active Hemostatic Agents Market Restraints
Figure 76. Active Hemostatic Agents Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Active Hemostatic Agents in 2022
Figure 79. Manufacturing Process Analysis of Active Hemostatic Agents
Figure 80. Active Hemostatic Agents Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
